Tokushima University / Educator and Researcher Directory --- Uesugi, Atsushi

Personal Web Page

https://researchmap.jp/7000028986 (researchmap)

https://orcid.org/0000-0002-0496-8591 (ORCID)

Field of Study

○	Molecular and Cellular Biology
○	Molecular Cell Biology

Subject of Study

○	Development of oral cancer treatment with novel microRNAs independently selected from functional screening (cancer, gene, cell, genome)
○	がん抑制型microRNAの経皮投与による新規治療法の開発 (gene, cancer)

Book / Paper

(See https://researchmap.jp/7000028986 (researchmap) for Published Book / Papers / Presentations.)

Academic Paper (Judged Full Paper):

1.	Kumiko Kamada, Natsumi Takamaru, Atsushi Uesugi, Kazuya Akita, Naoyuki Fukuda and Naito Kurio : Psychogenic Nonepileptic Seizures Following Orthognathic Surgery: A Case Report, Oral Science International, 23, 1, 2026. (Tokushima University Institutional Repository) ● Metadata: 2013873 (Tokushima University Institutional Repository: 2013873)
2.	Kumiko Kamada, Atsushi Uesugi, Yasusei Kudo, Takaaki Tsunematsu, Yoshiaki Kitamura and Naito Kurio : Durable partial response of pulmonary metastases from primary sublingual gland squamous cell carcinoma after pembrolizumab failure: Salvage therapy with paclitaxel plus cetuximab, Oral Oncology Reports, 16, 2025. (Keyword) Cetuximab / Paclitaxel / Pembrolizumab / Pulmonary metastasis / Salvage chemotherapy / Squamous cell carcinoma / Sublingual gland carcinoma (Link to Publication Site) ● Publication site (DOI): 10.1016/j.oor.2025.100768 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-105020587456 (DOI: 10.1016/j.oor.2025.100768, Elsevier: Scopus)
3.	Kumiko Kamada, Atsushi Uesugi, Naoyuki Fukuda, Natsumi Takamaru and Naito Kurio : Alveolar Ridge Bone Augmentation Using Carbonate Apatite Granules as a Novel Bone Substitute for Orthodontic Tooth Movement: A Report of the First Case, Curēus, 17, 9, e91521, 2025.
4.	Naito Kurio, Kumiko Kamada, Atsushi Uesugi, Takaaki Tsunematsu and Yasusei Kudo : A Case of Basal Cell Adenoma of the Buccal Mucosa, Journal of Oral Health and Biosciences, 37, 1, 18-23, 2024. (Summary) Basal cell adenoma (BCA) is a rare type of benign salivary gland tumor. It frequently occurs in the parotid glands but rarely in the minor salivary grands. We report a rare case of BCA of the buccal mucosa. A 81-year-old man presented to our department with a mass of his left side of buccal mucosa. Intraoral examination revealed an elastic-hard, mobile, well-circumscribed submucosal mass covered with normal mucosa, measuring about 15 mm in diameter. Ultrasonography showed well-defined hypoechoic area and slight blood flow. Clinical diagnosis was a benign buccal tumor. The tumor excision was performed under intravenous sedation. Since the tumor had distinct capsule and no adhesion with surrounding tissue, it was easily resected. Histopathological examination revealed that the tumor was encapsulated by thin fibrous connective tissue. Some tumor nests presented with biphasic tubular structure composed of inner luminal cells and outer basaloid and myoepithelial cells. Immunohistochemical examination revealed that the basaloid and the myoepithelial cells were positive for p63 and the luminal cells and the stromal cells were positive for S-100. Ki-67 labeling index was less than 1%. Histopathological diagnosis was BCA. The postoperative course was uneventful. Tumor recurrence has not been observed over 3 years. (Keyword) 基底細胞腺腫 / 頬粘膜 / S-100 蛋白 / 間質細胞 (Tokushima University Institutional Repository) ● Metadata: 2012440 (Link to Publication Site) ● Publication site (DOI): 10.20738/johb.37.1_18 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390583192735068800 ● Search Scopus @ Elsevier (DOI): 10.20738/johb.37.1_18 (Tokushima University Institutional Repository: 2012440, DOI: 10.20738/johb.37.1_18, CiNii: 1390583192735068800)
5.	Atsushi Uesugi, Fumihiko Tsushima, Youji Miyamoto and Hiroyuki Harada : Pollen food allergy syndrome caused by Japanese radish: A case report, Indian Journal of Dermatology, 68, 1, 123, 2023. (Summary) Pollen food allergy syndrome (PFAS) is a food allergy that manifests as hypersensitivity symptoms of the oropharyngeal mucosa on ingesting specific foods, and findings resemble herpetic gingivostomatitis. Few reports of PFAS caused by consuming radishes are found in the literature. A 31-year-old man presented to our department with stomatitis and pharyngeal pain. He had no history of allergies. Herpetic gingivostomatitis was suspected. He was admitted to the emergency room a few days later complaining of oral and epigastric pain. Symptoms were similar to those reported previously. He reported frequently consuming raw Japanese radish ( L.) which gave rise to his symptoms. Japanese radish was suspected as the allergen. The skin-prick test confirmed the diagnosis of PFAS. PFAS can be diagnosed easily once the food-causing symptoms are identified. Upon encountering widespread erosion in the oral cavity, it is essential to consider PFAS as the possible cause. (Keyword) herpetic gingivostomatitis / Japanese radish / pollen food allergy syndrome / Raphans sativus L. / skin prick test (Link to Publication Site) ● Publication site (DOI): 10.4103/ijd.ijd_405_22 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37151264 ● Search Scopus @ Elsevier (PMID): 37151264 ● Search Scopus @ Elsevier (DOI): 10.4103/ijd.ijd_405_22 (DOI: 10.4103/ijd.ijd_405_22, PubMed: 37151264)
6.	Yoshiko Yamamura, 鴨居耕平, Keiko Kudoh, Naito Kurio, Kumiko Kamada, 横田美保, Atsushi Uesugi and Youji Miyamoto : A Case of Ameloblastoma Removed Using a Three-dimensional Transparent Plastic Jaw Model Which Can Visualize Internal Jawbone Structures, Journal of Oral Health and Biosciences, 35, 1, 9-13, 2022. (Keyword) ameloblastoma / three-dimensional jaw model / three-dimensional printer / visualization (Tokushima University Institutional Repository) ● Metadata: 2010400 (Link to Publication Site) ● Publication site (DOI): 10.20738/johb.35.1_9 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390293412207632768 ● Search Scopus @ Elsevier (DOI): 10.20738/johb.35.1_9 (Tokushima University Institutional Repository: 2010400, DOI: 10.20738/johb.35.1_9, CiNii: 1390293412207632768)
7.	Fumihiko Tsushima, Jinkyo Sakurai, Atsushi Uesugi, Yu Oikawa, Toshimitu Ohsako, Yumi Mochizuki, Hideaki Hirai, Kou Kayamori and Hiroyuki Harada : Malignant transformation of oral lichen planus: a retrospective study of 565 Japanese patients, BMC Oral Health, 21, 1, 298, 2021. (Summary) Oral lichen planus (OLP) is a chronic inflammatory oral mucosa disease that is recognized as an oral potentially malignant disorder. However, the potentially malignant nature of OLP remains unclear. We designed this study to examine the demographic and clinical characteristics of patients with OLP and evaluate the associated malignant transformation rate. A total of 565 patients with a clinical and histopathological diagnosis of OLP who presented at our department between 2001 and 2017 were retrospectively studied. Patients who had clinical and histopathological features of oral lichenoid lesions (OLLs) classified as oral lichenoid contact lesions, oral lichenoid drug reactions and oral lichenoid lesions of graft-versus-host disease were excluded. The study population included 123 men and 442 women aged 21-93 years (mean ± standard deviation, 60.5 ± 11.8). The 565 patients were followed up for a duration of 55.9 ± 45.3 months, during which 4 (0.7%) patients developed squamous cell carcinoma (SCC). In three of these 4 patients who developed SCC, the clinical type of OLP was the red type. Our results suggested that OLP was associated with a low risk of malignant transformation. We recommend regular follow-up for OLP patients and clear differentiation of oral epithelial dysplasia and OLLs to enable early detection of malignant transformation. Further investigation of the clinical risk factors associated with malignant transformation is necessary. (Keyword) cancer / Oral mucosal disease (Tokushima University Institutional Repository) ● Metadata: 2010233 (Link to Publication Site) ● Publication site (DOI): 10.1186/s12903-021-01652-7 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34112142 ● Summary page in Scopus @ Elsevier: 2-s2.0-85107546382 (Tokushima University Institutional Repository: 2010233, DOI: 10.1186/s12903-021-01652-7, PubMed: 34112142, Elsevier: Scopus)
8.	Atsushi Uesugi, K. Mochida, H. Harada and H. Imai : Ossifying fibroma arising from the zygomatic arch: A case report, Journal of Stomatology, Oral and Maxillofacial Surgery, 121, 3, 288-291, 2019. (Summary) Ossifying fibroma (OF) is a rare type of tumor characterized by fibrous tissue proliferation with cementum- or bone-like hard tissue formation. Since its first report by Montgomery in 1927, several cases of OF have been reported; however, no cases of OF arising from the zygomatic arch have been reported. Herein, we report a case of OF arising from the zygomatic arch. A 70-year-old female visited our department in February 2017 because of a gradually growing osseous protrusion in the right zygomatic region, which she was aware of since the previous 6 months. A 3.3cm×3.2-cm area of swelling was observed in the region. Computed tomography confirmed the presence of a granulated lesion on the surface of the right zygomatic arch. Accordingly, benign bone tumor was diagnosed, and tumor resection was subsequently performed. Histopathological analysis revealed irregularly arranged bone trabeculae, an increased number of fibroblasts, and collagen fibers between the bone trabeculae; accordingly, OF was diagnosed. No clinical or radiographic evidence of recurrence was observed during the 1.5-year follow-up period. A granulated lesion was present on the surface of the right zygomatic arch, and the boundary between the lesion and surrounding bone was clear. Resection of the lesion from the zygomatic arch was relatively easy. Thus, OF was diagnosed. If OF is suspected, a risk of recurrence persists; therefore, shaving the area including the bones surrounding the lesion may be necessary. Although detailed causes of OF and osteoma remain unknown, past trauma has been indicated as a common etiology. However, compared with the frequency of fractures in the zygomatic arch, the frequency of OF and osteoma is rare; thus, the etiology of OF and osteoma remains to be fully elucidated. (Keyword) Ossifying fibroma / Zygomatic arch (Tokushima University Institutional Repository) ● Metadata: 2013265 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jormas.2019.08.004 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31476540 ● Summary page in Scopus @ Elsevier: 2-s2.0-85072280891 (Tokushima University Institutional Repository: 2013265, DOI: 10.1016/j.jormas.2019.08.004, PubMed: 31476540, Elsevier: Scopus)
9.	Yuri Kuribayashi, Fumihiko Tsushima, Ichi Kei Morita, Kanako Matsumoto, Jinkyo Sakurai, Atsushi Uesugi, Kiyoshi Sato, Seiichiro Oda, Kei Sakamoto and Hiroyuki Harada : Long-term outcome of non-surgical treatment in patients with oral leukoplakia, Oral Oncology, 51, 11, 1020-1025, 2015. (Summary) The standard treatments for oral leukoplakia range from careful observation to complete resection. No surgical intervention is chosen for several supposable reasons. Surgical treatment and no surgical treatment for oral leukoplakia have no defined basis for comparisons, and few studies have reported on the long-term outcomes of oral leukoplakia without surgery. This study aimed to identify the important factors using a long-term wait-and-see policy in patients with oral leukoplakia. In total, 237 lesions from 218 patients selected for non-surgical therapy between 2001 and 2010 were analyzed. On the basis of long-term follow-up data, lesions were classified as unchanged, reduced, disappeared, expanded, and malignantly transformed. In total, 135 (57.0%) lesions remained unchanged, 30 (12.7%) lesions were characterized by a reduction in size or clinical severity, and 44 (18.6%) lesions had disappeared. Another 17 (7.2%) lesions resulted in spread or clinical deterioration, and 11 (4.6%) lesions developed oral squamous cell carcinoma. We demonstrated a cumulative malignant transformation rate of 11.6% in 10years without resection. The lesions that were nonhomogeneous, and higher degree of epithelial dysplasia, located on the tongue were likely to progress into cancer. In addition, 32.5% of lesions without surgical treatment were reduced or disappeared. There is a possibility that removal of considerable irritation for a long time contributes to the treatment of this disease. The development of appropriate treatments for oral leukoplakia is required, which will enable successful differentiation between surgical and observation cases. (Keyword) Epithelial dysplasia / Malignant transformation / Oral leukoplakia (Link to Publication Site) ● Publication site (DOI): 10.1016/j.oraloncology.2015.09.004 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26410021 ● Summary page in Scopus @ Elsevier: 2-s2.0-84944716786 (DOI: 10.1016/j.oraloncology.2015.09.004, PubMed: 26410021, Elsevier: Scopus)
10.	Tomohiko Tsuruta, Ichi Ken Kozaki, Atsushi Uesugi, Mayuko Furuta, Akira Hirasawa, Issei Imoto, Nobuyuki Susumu, Daisuke Aoki and Johji Inazawa : miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer, Cancer Research, 71, 20, 6450-6462, 2011. (Summary) The etiology and development of human cancers that remain little understood might be enlightened by defining tumor suppressor microRNAs (TS-miRNA). In this study, we identified TS-miRNAs silenced by aberrant DNA hypermethylation in endometrial cancer. Functional screening of 327 synthetic miRNAs in an endometrial cancer cell proliferation assay identified 103 miRNAs that inhibited cell growth. We then determined the sequence, DNA methylation status, and expression levels of these miRNAs in endometrial cancer cell lines and primary tumors. These determinations led to the identification of miR-152 as a candidate TS-miRNA gene in endometrial cancer. Epigenetic silencing documented in miR-152 was consistent with its location at 17q21.32 in intron 1 of the COPZ2 gene, which is also silenced often in endometrial cancer by DNA hypermethylation, and also with evidence that miR-152 targets the DNA methyltransferase DNMT1. Notably, restoration of miR-152 expression in endometrial cancer cell lines was sufficient to inhibit tumor cell growth in vitro and in vivo. We identified E2F3, MET, and Rictor as novel candidate targets of miR-152, suggesting how its epigenetic silencing can drive endometrial carcinogenesis. Our findings define a central role for miR-152 in endometrial cancer, and they also suggest its use in new therapeutic strategies to treat this cancer. (Keyword) Adenocarcinoma / Carrier Proteins / Cell Line, Tumor / Cell Proliferation / Chromosomes, Human, Pair 17 / Coatomer Protein / DNA (Cytosine-5-)-Methyltransferase 1 / DNA (Cytosine-5-)-Methyltransferases / DNA Methylation / E2F3 Transcription Factor / Endometrial Neoplasms / Female / Gene Silencing / Genes, Tumor Suppressor / Humans / Introns / MicroRNAs / Proto-Oncogene Proteins c-met / Rapamycin-Insensitive Companion of mTOR Protein (Link to Publication Site) ● Publication site (DOI): 10.1158/0008-5472.CAN-11-0364 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21868754 ● Summary page in Scopus @ Elsevier: 2-s2.0-80054047147 (DOI: 10.1158/0008-5472.CAN-11-0364, PubMed: 21868754, Elsevier: Scopus)
11.	Atsushi Uesugi, Ichi Ken Kozaki, Tomohiko Tsuruta, Mayuko Furuta, Ichi Kei Morita, Issei Imoto, Ken Omura and Johji Inazawa : The tumor suppressive microRNA miR-218 targets the mTOR component rictor and inhibits AKT phosphorylation in oral cancer, Cancer Research, 71, 17, 5765-5778, 2011. (Summary) The incidence of oral squamous cell carcinoma (OSCC) is rising rapidly in developed countries, posing a growing challenge due to the poor management of this type of malignancy at present. In this study, we profiled tumor suppressive microRNAs (miRNAs) that are silenced by DNA hypermethylation in OSCC using a function-based screening approach. This approach employed a cell proliferation assay for 327 synthetic miRNAs in two OSCC cell lines. Among the 110 miRNAs identified in this set that exhibited inhibitory properties, we compared DNA methylation and expression status in a wider panel of OSCC cell lines and primary tumor tissues, resulting in the identification of miR-218 and miR-585 as functionally significant miRNA genes that are frequently silenced in OSCC by DNA hypermethylation. Ectopic expression of miR-218 and miR-585 in OSCC cells lacking endogenous expression reduced cell growth in part through caspase-mediated apoptosis. Notably, miR-218 reduced levels of the rapamycin-insensitive component of mTOR, Rictor, in a manner associated with a suppression of Akt S473 phosphorylation. Together our findings define miR-585 as a tumor suppressive function that is often epigenetically silenced in OSCC, and they identify Rictor as a novel target of miR-218, suggesting that activation of the mTOR-Akt signaling pathway induced by Rictor contributes centrally to oral carcinogenesis. (Keyword) Carcinoma, Squamous Cell / Carrier Proteins / Cell Line, Tumor / Cell Transformation, Neoplastic / Genes, Tumor Suppressor / Humans / MicroRNAs / Mouth Neoplasms / Phosphorylation / Proto-Oncogene Proteins c-akt / Rapamycin-Insensitive Companion of mTOR Protein / TOR Serine-Threonine Kinases (Link to Publication Site) ● Publication site (DOI): 10.1158/0008-5472.CAN-11-0368 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21795477 ● Summary page in Scopus @ Elsevier: 2-s2.0-80052218238 (DOI: 10.1158/0008-5472.CAN-11-0368, PubMed: 21795477, Elsevier: Scopus)

Academic Paper (Unrefereed Paper):

1.	Atsushi Uesugi, Fumihiko Tsushima, Makoto Kodama, Takeshi Kuroshima, Jinkyo Sakurai and Hiroyuki Harada : Oral granuloma in a pediatric patient with chronic graft-versus-host disease: a case report, World Journal of Clinical Cases, 8, 22, 5663-5669, 2020. (Summary) Oral mucositis is often observed with graft-versus-host disease (GVHD); however, the occurrence of oral granuloma is rare. The rapid increase in granulomatous lesions should be distinguished from malignant tumors in patients with GVHD because malignant diseases can develop in those patients. This case is the youngest pediatric patient with granuloma associated with GVHD. The patient was a 1-year and 5-mo-old girl who presented to our department for the management of oral nodules. At the age of 5 mo, she was diagnosed with primary immunodeficiency disease, cord blood transplant was performed at 11 mo and bone marrow transplant at 1 year of age. After transplantation, GVHD and oral mucositis developed, and tacrolimus was administered. Interestingly, nodules appeared on the lower lip and buccal mucosa, which spontaneously disappeared. Then, a new nodule appeared on the left lateral border of the tongue. Resection was performed and the histopathological diagnosis was granuloma. The origin of these nodules were considered to be the fibroblasts activated under inflammation caused by GVHD because the calcineurin inhibitor tacrolimus acted on their proliferation. It is very important to distinguish oral granulomatous lesions from malignancies if GVHD is present at the base and if immunosuppressive agents and steroids are being administered. (Tokushima University Institutional Repository) ● Metadata: 2009091 (Link to Publication Site) ● Publication site (DOI): 10.12998/wjcc.v8.i22.5663 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33344558 ● Search Scopus @ Elsevier (PMID): 33344558 ● Search Scopus @ Elsevier (DOI): 10.12998/wjcc.v8.i22.5663 (Tokushima University Institutional Repository: 2009091, DOI: 10.12998/wjcc.v8.i22.5663, PubMed: 33344558)

Proceeding of Domestic Conference:

1.	Keiko Kudoh, Atsushi Uesugi, Kumiko Kamada, 赤井亨輔, Natsumi Takamaru, Naoyuki Fukuda, Kazuya Akita and Naito Kurio : 全身麻酔導入後にアナフィラキシーショックを生じた舌癌の1例, 第55回(公社)日本口腔外科学会中国四国支部学術集会, May 2026.
2.	Kumiko Kamada, Atsushi Uesugi, Kazuya Akita, Naoyuki Fukuda, Natsumi Takamaru, Takaaki Tsunematsu and Naito Kurio : 上顎骨に発生した骨膜性骨肉腫のまれな1例, 第44回日本口腔腫瘍学会学術大会, Jan. 2026.
3.	Keiko Kudoh, Natsumi Takamaru, Takaharu Kudoh, Atsushi Uesugi, Naoyuki Fukuda, Kumiko Kamada, Kazuya Akita and Naito Kurio : Accidental insertion of iatrogenic foreign bodies in the maxillary sinus: Clinical study of 17 cases, 第70回公益社団法人日本口腔外科学会総会・学術大会, Nov. 2025.
4.	Kumiko Kamada, Atsushi Uesugi, 赤井亨輔, Keiko Kudoh, MATSUZAWA Shigefumi, Takaaki Tsunematsu and Naito Kurio : 上顎骨に発生した骨膜性骨肉腫の1 例, 第70回公益社団法人日本口腔外科学会・学術大会, Nov. 2025.
5.	鄭路洋, Kazuya Akita, Natsumi Takamaru, Yukihiro Nogami, Naoyuki Fukuda, Kumiko Kamada, Atsushi Uesugi, Keiko Kudoh and Naito Kurio : 造血幹細胞移植後の慢性GVHD 患者に生じた口腔内異時性多発癌の1 例, 第72回 NPO法人日本口腔科学会中国・四国地方部会, Oct. 2025.
6.	Yuki Matsumura, Kumiko Kamada, Atsushi Uesugi, 山村佳子, Naito Kurio, Yasusei Kudo and Natsumi Fujiwara : 口腔がん局所における細菌叢とFusobacterium臨床分離株の病原性の検討, 第72回日本口腔科学会中国・四国地方部会, Oct. 2025.
7.	Kumiko Kamada, Atsushi Uesugi, Kazuya Akita, Naoyuki Fukuda, Natsumi Takamaru, Keiko Kudoh, Yasusei Kudo and Naito Kurio : Combination treatment with hyaluronic acid synthesis and Bcl2 inhibitors induces senolytic elimination of oral squamous cell carcinoma cells in vitro, 第79回NPO法人日本口腔科学学会学術集会, May 2025.
8.	山之内雄大, Keiko Kudoh, Natsumi Takamaru, Takaharu Kudoh, Atsushi Uesugi, Naoyuki Fukuda, Kazuya Akita, Kumiko Kamada, 赤井亨輔, 野上幸裕 and Naito Kurio : 当科を受診した破傷風4症例の臨床的検討, 第54回(公社)日本口腔外科学会中国四国支部学術集会, Apr. 2025.
9.	Keiko Kudoh, Natsumi Takamaru, Takaharu Kudoh, Atsushi Uesugi, Naoyuki Fukuda, Kumiko Kamada, Kazuya Akita, 赤井亨輔, 野上幸裕 and Naito Kurio : Mandibular osteomyelitis in a patient with ulcerative colitis possibly associated with infliximab: A case report, 第69回公益社団法人日本口腔外科学会総会・学術大会, Nov. 2024.
10.	Atsushi Uesugi, kyousuke Akai, Kumiko Kamada, Takaharu Kudoh, Keiko Kudoh and Naito Kurio : 上顎病変を契機に診断されたランゲルハンス細胞組織球症の1例, 第71回NPO法人日本口腔科学会中国・四国地方部会, Oct. 2024.
11.	Atsushi Uesugi, Kumiko Kamada, Kyousuke Akai and Naito Kurio : A case of adult Langerhans cell histiocytosis diagnosed with maxillary lesions, 第37 回日本口腔診断学会第34回日本口腔内科学会合同学術大会, Sep. 2024.
12.	赤井享輔, Kumiko Kamada, Atsushi Uesugi and Naito Kurio : 咀嚼困難を契機に診断された重症筋無力症の一例, 第53回口腔外科学会中国四国支部学術集会, Jun. 2024.
13.	Naito Kurio, Kumiko Kamada, Atsushi Uesugi, 横田美保, 赤井亨輔, Yoshiko Yamamura, Akira Takahashi and Youji Miyamoto : ヒアルロン酸阻害薬による口腔扁平上皮癌細胞の老化誘導とsenolytic therapy, 第68回日本口腔外科学会総会・学術大会, Nov. 2023.
14.	Atsushi Uesugi, Naito Kurio, 赤井亨輔, 横田美保, Kumiko Kamada and 宮本洋二 : A case of recurrent ameloblastoma in the mandibular ramus resected using a high perimandibular approach, 第52回日本口腔外科学会中国四国支部学術集会, Jul. 2023.
15.	Atsushi Uesugi, Naito Kurio, Kumiko Kamada, 横田美保, Keiko Kudoh and Youji Miyamoto : 機能的スクリーニングによる新規の口腔癌関連癌抑制microRNAの検索, 第67回公益社団法人日本口腔外科学会総会・学術大会, Nov. 2022.
16.	Kumiko Kamada, Naito Kurio, Atsushi Uesugi, Yoshiko Yamamura and Youji Miyamoto : 口腔扁平上皮癌細胞株に対するヒアルロン酸合成阻害の抗腫瘍効果, 第67回公益社団法人日本口腔外科学会総会・学術大会, Nov. 2022.
17.	横田美保, Naito Kurio, Kumiko Kamada, Atsushi Uesugi and Youji Miyamoto : 翼突鉤切除を行ったPterygoid hamulus bursitisの1例, 第69回(公社)日本口腔科学会中国四国支部学術集会, Oct. 2022.
18.	Kumiko Kamada, Naito Kurio, Atsushi Uesugi, 横田美保, Kazuya Akita, Naoyuki Fukuda, Yoshiko Yamamura, Takaharu Kudoh, Natsumi Takamaru, Keiko Kudoh, Akira Takahashi and Youji Miyamoto : 歯性感染症により発症した側頭部ガス壊疽の1例, 第50回(公社)日本口腔外科学会中国四国支部学術集会, Jan. 2022.
19.	Kazuya Akita, Naoyuki Fukuda, Kumiko Kamada, Atsushi Uesugi, Yoshiko Yamamura, Takaharu Kudoh, Natsumi Takamaru, Keiko Kudoh, Naito Kurio, Akira Takahashi and Youji Miyamoto : 炭酸アパタイト顆粒(サイトランスグラニュール)を用いて歯槽骨造成を行った2例, 第68 回NPO 法人日本口腔科学会中国・四国地方部会, Nov. 2021.
20.	Yoshiko Yamamura, Yasusei Kudo, Kumiko Kamada, Naito Kurio, 横田美保, Atsushi Uesugi and Youji Miyamoto : 唾液腺の発達・再生におけるΔNp63-Nrep axisの役割, 第66回日本口腔外科学会総会・学術大会, Nov. 2021.
21.	Kumiko Kamada, Naito Kurio, Naoyuki Fukuda, 横田美保, Kazuya Akita, Atsushi Uesugi, Yoshiko Yamamura, Takaharu Kudoh, Akira Takahashi and 宮本洋二 : 口腔癌術後に多発肺結節を認めた敗血症性肺塞栓症の一例, 第49回(公社)日本口腔外科学会中国四国支部学術集会, Feb. 2021.
22.	Atsushi Uesugi, 津島文彦, Youji Miyamoto and 原田浩之 : 大根おろしによる口腔アレルギー症候群の一例, 第33回日本口腔診断学会，第30回日本口腔内科学会, Oct. 2020.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

ヒアルロン酸合成阻害薬とMEK阻害剤による口腔がんの老化誘導除去療法の開発 (Project/Area Number: 25K13185 )
がん抑制型microRNAの経皮投与による新規治療法の開発 (Project/Area Number: 24K13158 )
頸部リンパ節転移の超早期診断の挑戦-転移可視化モデルの樹立と超音波診断法の構築 (Project/Area Number: 24K13133 )
ヒアルロン酸合成阻害剤による口腔癌のBcl2発現増強を標的とした老化細胞除去療法 (Project/Area Number: 24K13090 )
Development of oral cancer treatment using novel microRNAs selected through functional screening (Project/Area Number: 21K10140 )
Functional screening of tumor suppressive microRNA and application to nucleic acid medicine (Project/Area Number: 25861918 )
Search by Researcher Number (20637061)

Assistant Professor : Uesugi, Atsushi

Research

Personal Web Page

Field of Study

Subject of Study

Book / Paper

Academic Paper (Judged Full Paper):

Academic Paper (Unrefereed Paper):

Proceeding of Domestic Conference:

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)